Institutional members access full text with Ovid®

Share this article on:

The Effects of Intrastromal Voriconazole Injection and Topical Voriconazole in the Treatment of Recalcitrant Fusarium Keratitis

Siatiri, Heidar MD*; Daneshgar, Farid MD*; Siatiri, Nasim MD†; Khodabande, Alireza MD†

doi: 10.1097/ICO.0b013e3182100993
Clinical Science

Purpose: To describe the course and outcome in 3 patients with recalcitrant fungal keratitis treated with intrastromal voriconazole injection and topical voriconazole application.

Methods: The present study was an interventional case series. A 50 μg/0.1 mL solution of voriconazole was injected into the corneal stromal tissue around the corneal ulcer, and 1% topical voriconazole was added to the therapeutic regimen if the ulcer failed to respond to 5% topical natamycin hourly and oral ketoconazole twice per day. The infiltration and epithelial defect size were measured at each visit using a slit-lamp biomicroscope. Anatomical outcomes were assessed.

Results: A dramatic therapeutic response was observed in 2 patients. An amniotic membrane transplantation using cyanoacrylate glue was required to seal the microperforation in a patient with a chemical burn superinfected with Fusarium.

Conclusions: Intrastromal injection of voriconazole together with topical voriconazole effectively reduced the infiltration size and controlled the infection in patients with Fusarium keratitis. However, continued application of the topical medication is critical for a favorable outcome of treatment.

From the *Cornea Department; †Ophthalmic Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran 1336616351, Iran.

Received for publication February 10, 2010; revision received January 5, 2011; accepted January 11, 2011.

The authors state that they have no proprietary or conflicts of interest to disclose.

Reprints: Farid Daneshgar, Anterior Segment Department, Farabi Eye Hospital, Qazwin Sq, Kargar St, Tehran, Iran (e-mail: daneshgar@razi.tums.ac.ir).

© 2011 Lippincott Williams & Wilkins, Inc.